Fifth Third Bancorp
VIVO

Fifth Third Bancorp’s Meridian Bioscience Inc VIVO Stock Holding History

Fifth Third Bancorp’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,634
Closed -$154K – 2865
2022
Q4 		$154K Buy
4,634
+33
+0.7% +$1.06K ﹤0.01% 1001
2022
Q3 		$145K Hold
4,601
– – ﹤0.01% 1012
2022
Q2 		$140K Hold
4,601
– – ﹤0.01% 1061
2022
Q1 		$119K Hold
4,601
– – ﹤0.01% 1140
2021
Q4 		$94K Buy
4,601
+127
+3% +$2.44K ﹤0.01% 1257
2021
Q3 		$86K Buy
4,474
+99
+2% +$1.97K ﹤0.01% 1233
2021
Q2 		$97K Hold
4,375
– – ﹤0.01% 1203
2021
Q1 		$115K Sell
4,375
-300
-6% -$7.13K ﹤0.01% 1114
2020
Q4 		$87K Sell
4,675
-69,700
-94% -$1.3M ﹤0.01% 1195
2020
Q3 		$1.26M Hold
74,375
– – 0.01% 486
2020
Q2 		$1.73M Sell
74,375
-71,105
-49% -$1.03M 0.01% 422
2020
Q1 		$1.22M Sell
145,480
-26,126
-15% -$220K 0.01% 444
2019
Q4 		$1.68M Buy
171,606
+2,500
+1% +$23.5K 0.01% 449
2019
Q3 		$1.6M Hold
169,106
– – 0.01% 445
2019
Q2 		$2.01M Buy
169,106
+28,693
+20% +$346K 0.01% 403
2019
Q1 		$2.47M Buy
140,413
+13,968
+11% +$232K 0.02% 363
2018
Q4 		$2.19M Hold
126,445
– – 0.02% 361
2018
Q3 		$1.88M Sell
126,445
-413
-0.3% -$6.4K 0.01% 403
2018
Q2 		$2.02M Sell
126,858
-49,640
-28% -$740K 0.01% 380
2018
Q1 		$2.51M Sell
176,498
-100,000
-36% -$1.48M 0.02% 358
2017
Q4 		$3.87M Hold
276,498
– – 0.03% 304
2017
Q3 		$3.95M Buy
276,498
+59,595
+27% +$851K 0.03% 302
2017
Q2 		$3.42M Buy
216,903
+90
+0% +$1.3K 0.03% 314
2017
Q1 		$2.99M Hold
216,813
– – 0.02% 343
2016
Q4 		$3.84M Sell
216,813
-87,500
-29% -$1.54M 0.03% 321
2016
Q3 		$5.87M Sell
304,313
-47,556
-14% -$931K 0.05% 259
2016
Q2 		$6.86M Sell
351,869
-96,859
-22% -$1.9M 0.06% 233
2016
Q1 		$9.25M Sell
448,728
-16,338
-4% -$322K 0.08% 214
2015
Q4 		$9.54M Sell
465,066
-14,191
-3% -$272K 0.08% 208
2015
Q3 		$8.2M Sell
479,257
-1,807
-0.4% -$33K 0.08% 212
2015
Q2 		$8.97M Buy
481,064
+1
+0% +$19 0.08% 206
2015
Q1 		$9.18M Buy
481,063
+2,491
+0.5% +$46.1K 0.08% 211
2014
Q4 		$7.88M Buy
478,572
+2,153
+0.5% +$36.9K 0.07% 236
2014
Q3 		$8.43M Buy
476,419
+3,485
+0.7% +$68.5K 0.08% 216
2014
Q2 		$9.76M Buy
472,934
+335,983
+245% +$6.9M 0.09% 199
2014
Q1 		$2.98M Buy
136,951
+1,480
+1% +$33.9K 0.03% 373
2013
Q4 		$3.59M Sell
135,471
-239
-0.2% -$5.87K 0.03% 337
2013
Q3 		$3.21M Buy
135,710
+200
+0.1% +$4.67K 0.03% 352
2013
Q2 		$2.91M Buy
+135,510
New +$2.92M 0.03% 360

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fifth Third Bancorp's VIVO Position: Q1 2023 in Review

Fifth Third Bancorp sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 4,634 shares — an estimated $154K sold.

Fifth Third Bancorp first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $9.76M in Q2 2014. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Fifth Third Bancorp reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Fifth Third Bancorp sold 4,634 Meridian Bioscience Inc shares in Q1 2023, an estimated $154K.
  • Fifth Third Bancorp first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Fifth Third Bancorp's Meridian Bioscience Inc position peaked at $9.76M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Fifth Third Bancorp's 13F filing for Q1 2023, filed 24 Apr 2023.